| Literature DB >> 31521147 |
Sicheng Zhou1, Xuewei Wang1, Chuanduo Zhao1, Qian Liu1, Haitao Zhou1, Zhaoxu Zheng1, Zhixiang Zhou1, Xishan Wang1, Jianwei Liang2.
Abstract
BACKGROUND: Colorectal cancer is common in elderly patients. Laparoscopy is widely used to approach this kind of disease. This study was to examine short-term outcomes and long-term survival for laparoscopic and open surgery in elderly patients with colorectal cancer.Entities:
Keywords: Colorectal cancer; Elderly patients; Laparoscopic surgery; Open surgery; Surgical outcomes
Mesh:
Year: 2019 PMID: 31521147 PMCID: PMC6744685 DOI: 10.1186/s12893-019-0596-3
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Clinical and pathological characteristics of elderly patients with colorectal cancer before and after matching
| Variables | Total cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
| OPEN ( | LAP ( |
| OPEN ( | LAP ( |
| |
| Age (years, mean ± SD) (range) | 82.3 ± 2.1 (80–92) | 82 ± 2.1 (80–94) | 0.280 | 82.1 ± 2.1 (80–92) | 82.0 ± 2.2 (80–94) | 0.814 |
| Gender | 0.445 | 0.655 | ||||
| Male | 91 (63.6%) | 101 (59.4%) | 56 (60.2%) | 53 (57%) | ||
| Female | 52 (36.4%) | 69 (40.6%) | 37 (39.8%) | 40 (43%) | ||
| BMI (kg/m2, mean ± SD) (range) | 22.7 ± 3.3 (15.8–33.8) | 23.7 ± 3.3 (15.6–34.1) | 0.009 | 23.4 ± 3.0 (15.8–33.8) | 23.2 ± 3.3 (16.8–34.1) | 0.703 |
| Preoperative HGB (g/L, mean ± SD) (range) | 120.0 ± 19.1 (49–165) | 124.5 ± 18.7 (62–161) | 0.045 | 120.2 ± 19.6 (49–165) | 121.5 ± 19.2 (62–161) | 0.645 |
| Preoperative albumin (g/L, mean ± SD) (range) | 37.2 ± 4.3 (26.8–46.2) | 40.2 ± 4.1 (29.1–46.8) | < 0.001 | 38.4 ± 4.0 (29.5–46.2) | 38.9 ± 4.0 (29.1–46.2) | 0.409 |
| ASA score | < 0.001 | 0.378 | ||||
| I-II | 52 (36.4%) | 111 (65.3%) | 47 (50.5%) | 53 (57%) | ||
| III-IV | 91 (63.6%) | 59 (34.7%) | 46 (49.5%) | 40 (43%) | ||
| Comorbidity | 0.008 | 0.761 | ||||
| Yes | 83 (58.0%) | 123 (72.4%) | 60 (64.5%) | 58 (62.4%) | ||
| No | 60 (42.0%) | 47 (27.6%) | 33 (35.5%) | 35 (37.6%) | ||
| Previous abdominal surgery | 0.456 | 0.721 | ||||
| Yes | 30 (21.0%) | 30 (17.6%) | 19 (20.4%) | 21 (22.6%) | ||
| No | 113 (79.0) | 140 (82.4) | 74 (79.6) | 72 (77.4) | ||
| Tumor location | 0.007 | 0.698 | ||||
| Right colon | 51 (35.7%) | 39 (23%) | 32 (34.4%) | 31 (33.3%) | ||
| Left colon | 10 (6.9%) | 4 (2.3%) | 7 (7.5%) | 4 (4.3%) | ||
| Sigmoid colon | 31 (21.7%) | 42 (24.7%) | 21 (22.6%) | 19 (20.4%) | ||
| Rectum | 51 (35.7%) | 85 (50%) | 33 (35.5%) | 39 (42%) | ||
| Tumor differentiation | 0.029 | 0.895 | ||||
| Poor | 29 (20.3%) | 45 (26.5%) | 23 (24.7%) | 24 (25.8%) | ||
| Median | 105 (73.4%) | 123 (72.4%) | 67 (72%) | 67 (72%) | ||
| High | 9 (6.3%) | 2 (1.1%) | 3 (3.3%) | 2 (2.1%) | ||
| TNM stage* | 0.213 | 0.860 | ||||
| I | 8 (5.6%) | 12 (7.1%) | 8 (8.6%) | 10 (10.8%) | ||
| II | 45 (31.5%) | 43 (25.3%) | 30 (32.2%) | 27 (29.0%) | ||
| III | 83 (58.0%) | 112 (65.8%) | 53 (57.0%) | 55 (59.1%) | ||
| IV | 7 (4.9%) | 3 (1.8%) | 2 (2.2%) | 1 (1.1%) | ||
| Preoperative CEA (ng/mL) | 0.503 | |||||
| ≤ 5 | 102 (71.3%) | 133 (78.2%) | 0.159 | 67 (72%) | 71 (76.3%) | |
| > 5 | 41 (28.7%) | 37 (21.8%) | 26 (28%) | 22 (23.7%) | ||
OPEN open surgery; LAP laparoscopic surgery; BMI body mex index; HGB hemoglobin; ASA American Society of Anesthesiologists; TNM tumor nodes metastasis; CEA carcinoembryonic antigen; SD standard deviation; * evaluated based on 7th edition of AJCC
Perioperative outcomes of 186 elderly patients with colorectal cancer in matched cohorts
| Variables | OPEN ( | LAP ( |
|
|---|---|---|---|
| Surgical outcome | |||
| Duration of operation (min, mean ± SD) (range) | 149.1 ± 53.9 (45–350) | 161.2 ± 55.3 (65–380) | 0.064 |
| Intraoperative blood loss (mL, mean ± SD) (range) | 108.1 ± 78.5 (10–400) | 50.9 ± 44.9 (10–200) | < 0.001 |
| Blood transfusion | 21 (22.6%) | 15 (16.1%) | 0.265 |
| Intraoperative complication | 0 (0%) | 1 (1.1%) | 1.000 |
| Postoperative complication | 25 (26.9%) | 10 (10.8%) | 0.005 |
| Wound infection | 9 (9.7%) | 1 (1.1%) | 0.009 |
| Anastomosis leakage | 4 (4.3%) | 2 (2.2%) | 0.678 |
| Ileus | 5 (5.4%) | 2 (2.2%) | 0.441 |
| Uroschesis | 1 (1.1%) | 1 (1.1%) | 1.000 |
| Pneumonia | 3 (3.2%) | 2 (2.2%) | 1.000 |
| Pelvic abscess | 0 (0%) | 1 (1.1%) | 1.000 |
| Arrhythmia | 3 (3.2%) | 1 (1.1%) | 1.000 |
| Pleural effusion | 2 (2.1%) | 0 (0%) | 0.477 |
| Delayed gastric emptying | 4 (4.3%) | 1 (1.1%) | 0.365 |
| Bacteremia | 1 (1.1%) | 0 (0%) | 1.000 |
| Postoperative complication (ClavienDindo classification) | |||
| I-II | 16 (17.2%) | 6 (6.5%) | 0.023 |
| III-V | 9 (9.7%) | 4 (4.3%) | 0.150 |
| Mortality | 0 (0%) | 0 (0%) | – |
| ICU staying | 13 (13.9%) | 7 (7.5%) | 0.156 |
| Pathological outcome | |||
| Retrieved lymph node (mean ± SD) (range) | 17.2 ± 9.1 (1–55) | 20.3 ± 10.5 (5–58) | 0.030 |
| Tumor size | 0.378 | ||
| < 5 cm | 46 (49.5%) | 52 (55.9%) | |
| ≥ 5 cm | 47 (50.5%) | 41 (44.1%) | |
| Perineural invasion | 22 (23.7%) | 18 (19.4%) | 0.475 |
| Vascular invasion | 28 (30.1%) | 24 (25.8%) | 0.513 |
| Positive CRM | 1 (1.1%) | 0 (0%) | 0.316 |
| Postoperative recovery | |||
OP open surgery; LAP laparoscopic surgery; CRM circumferential resection margin
Fig. 1Overall Survival curve in matched cohort of laparoscopic and open groups. In the matched cohort, in the laparoscopic group, 3- year and 5-year Overall survival rates were 83.9 and 73.1% respectively and they were 79.6 and 63.4% respectively in the open group. There was no significant difference between the laparoscopic and open groups (P = 0.224)
Fig. 2Disease-free curve in matched cohort of laparoscopic and open group. In the matched cohort, in the laparoscopic group, 3- year and 5-year disease-free survival rates were 76.3 and 69.9% respectively and they were 66.6 and 53.8% respectively in the open group. There was no significant difference between the laparoscopic and open groups (P = 0.230)
Univariate and multivariate analysis for overall survival and disease-free survival in matched cohorts
| Variables | Overall survival | Disease-free survival | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95%CI) |
| HR (95%CI) |
| HR (95%CI) |
| HR (95%CI) |
| |
| Gender: male/female | 1.11 (0.60–2.08) | 0.739 | 0.72 (0.42–1.23) | 0.225 | ||||
| Operative type: open/lap.* | 1.30 (0.76–2.15) | 0.224 | 1.41 (0.80–2.47) | 0.230 | ||||
| CEA > 5 | 1.53 (1.11–3.58) | 0.008 | 2.32 (1.26–4.98) | 0.022 | 2.35 (1.85–4.39) | < 0.001 | 1.77 (1.29–4.15) | 0.038 |
| ASA: I-II/III-IV | 0.93 (0.73–1.94) | 0.811 | 1.25 (0.64–2.13) | 0.410 | ||||
| Comorbidity | 1.32 (0.78–2.33) | 0.222 | 1.06 (0.53–1.51) | 0.639 | ||||
| Tumor size ≥5 cm | 1.49 (0.97–2.95) | 0.156 | 1.14 (0.63–1.97) | 0.443 | ||||
| N stage | ||||||||
| N0 | Reference | – | Reference | – | Reference | – | Reference | – |
| N1 | 3.60 (1.56–8.30) | 0.003 | 0.36 (0.05–2.77) | 0.324 | 3.93 (1.94–7.96) | < 0.001 | 0.45 (0.06–3.46) | 0.444 |
| N2 | 14.37 (6.11–33.82) | < 0.001 | 1.03 (0.16–1.59) | 0.854 | 12.25 (5.91–25.43) | < 0.001 | 1.46 (0.20–2.30) | 0.714 |
| TNM stage: I-II/III-IV | 6.43 (2.93–14.10) | < 0.001 | 9.82 (3.15–83.55) | 0.002 | 6.26 (3.22–12.18) | < 0.001 | 9.67 (3.18–79.30) | 0.012 |
| Differentiation | 0.61 (0.31–1.21) | 0.157 | ||||||
| Poor | Reference | – | Reference | – | Reference | – | ||
| Median | 0.63 (0.32–1.25) | 0.189 | 0.80 (0.52–1.47) | 0.286 | ||||
| High | 0.72 (0.40–1.53) | 0.279 | 0.75 (0.45–1.33) | 0.248 | ||||
| Perineural invasion | 4.24 (2.21–8.14) | < 0.001 | 1.57 (1.15–3.21) | 0.041 | 2.12 (1.42–4.25) | 0.002 | 2.09 (1.59–5.32) | 0.020 |
| Vascular invasion | 2.72 (1.44–5.14) | 0.002 | 1.23 (0.61–2.47) | 0.075 | 1.78 (1.02–3.09) | 0.041 | 1.63 (0.88–2.95) | 0.133 |
| Retrieved lymph node | 0.85 (0.71–1.72) | 0.533 | 0.79 (0.51–1.43) | 0.273 | ||||
| Postoperative complication | 0.96 (0.84–1.98) | 0.857 | 1.32 (0.70–2.41) | 0.396 | ||||
*lap laparoscopic